Skip to main content

Advertisement

SpringerLink
Log in

Soy, garlic, and ginkgo biloba: Their potential role in cardiovascular disease prevention and treatment

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

There are hundreds of foods, nutrients, herbs, and botanicals that have “bioactive” constituents with potential human health benefits. Three of these are discussed in this review: soy, garlic, and ginkgo biloba. Each of these three choices involves an ingestible item composed of a complex mixture of bioactive agents. For each of these three, there is a large and growing body of research suggesting potential cardiovascular health benefits. And for each there is at least some level of disagreement or controversy. The focus of this review is on results from recent human clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anderson JW, Johnstone BM, Cook-Newell ME: Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995, 333:276–282.

    Article  PubMed  CAS  Google Scholar 

  2. Simons LA, von Konigsmark M, Simons J, Celermajer DS: Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am J Cardiol 2000, 85:1297–1301.

    Article  PubMed  CAS  Google Scholar 

  3. Erdman JW: Soy protein and cardiovascular disease: a statement for healthcare professionals from the nutrition committee of the AHA. Circulation 2000, 102:2555–2559.

    PubMed  CAS  Google Scholar 

  4. Crouse JR 3rd, Morgan T, Terry JG, et al.: A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch Intern Med 1999, 159:2070–2076.

    Article  PubMed  CAS  Google Scholar 

  5. Lichtenstein AH, Jalbert SM, Adercreutz H, et al.: Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects. Arterioscler Thromb Vasc Biol 2002, 22:1852–1858.

    Article  PubMed  CAS  Google Scholar 

  6. Jenkins DJ, Kendall CW, Jackson CJ, et al.: Effects of high-and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am J Clin Nutr 2002, 76:365–372.

    PubMed  CAS  Google Scholar 

  7. Steinberg FM, Guthrie NL, Villablanca AC, et al.: Soy protein with isoflavones has favorable effects on endothelial function that are independent of lipid and antioxidant effects in healthy postmenopausal women. Am J Clin Nutr 2003, 78:123–130.

    PubMed  CAS  Google Scholar 

  8. Urban D, Irwin W, Kirk M, et al.: The effect of isolated soy protein on plasma biomarkers in elderly men with elevated serum prostate specific antigen. J Urol 2001, 165:294–300.

    Article  PubMed  CAS  Google Scholar 

  9. Setchell KD, Brown NM, Lydeking-Olsen E: The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 2002, 132:3577–3584.

    PubMed  CAS  Google Scholar 

  10. Teixeira SR, Potter SM, Weigel R, et al.: Effects of feeding 4 levels of soy protein for 3 and 6 wk on blood lipids and apolipoproteins in moderately hypercholesterolemic men. Am J Clin Nutr 2000, 71:1077–1084.

    PubMed  CAS  Google Scholar 

  11. Gardner C, Newell K, Cherin R, Haskell W: The effect of soy protein with or without isoflavones relative to milk protein on plasma lipids in hypercholesterolemic postmenopausal women. Am J Clin Nutr 2001, 73:728–735.

    PubMed  CAS  Google Scholar 

  12. Tonstad S, Smerud K, Hoie L: A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects. Am J Clin Nutr 2002, 76:78–84.

    PubMed  CAS  Google Scholar 

  13. Teede HJ, McGrath BP, DeSilva L, et al.: Isoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal women. Arterioscler Thromb Vasc Biol 2003, 23:1066–1071.

    Article  PubMed  CAS  Google Scholar 

  14. Wiseman H, O’Reilly JD, Adlercreutz H, et al.: Isoflavone phytoestrogens consumed in soy decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 2000, 72:395–400.

    PubMed  CAS  Google Scholar 

  15. Squadrito F, Altavilla D, Morabito N, et al.: The effect of the phytoestrogen genistein on plasma nitric oxide concentrations, endothelin-1 levels and endothelium dependent vasodilation in postmenopausal women. Atherosclerosis 2002, 163:339–347.

    Article  PubMed  CAS  Google Scholar 

  16. Blum A, Lang N, Vigder F, et al.: Effects of soy protein on endothelium-dependent vasodilatation and lipid profile in postmenopausal women with mild hypercholesterolemia. Clin Invest Med 2003, 26:20–26.

    PubMed  CAS  Google Scholar 

  17. Schoene NW, Guidry CA: Dietary soy inhibits activation of rat platelets. J Nutr Biochem 1999, 10:421–426.

    Article  PubMed  CAS  Google Scholar 

  18. Pan W, Ikeda K, Takebe M, Yamori Y: Genistein, daidzein and glycitein inhibit growth and DNA synthesis of aortic smooth muscle cells from stroke-prone spontaneously hypertensive rats. J Nutr 2001, 131:1154–1158.

    PubMed  CAS  Google Scholar 

  19. Jenkins DJ, Kendall CW, Faulkner D, et al.: A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism 2002, 51:1596–1604.

    Article  PubMed  CAS  Google Scholar 

  20. Koch H, Lawson L: Garlic: The Science and Therapeutic Application of Allium sativum L. and Related Species. Philadelphia: Williams & Wilkins; 1996.

    Google Scholar 

  21. Mulrow C, Lawrence V, Ackermann R, et al.: Garlic: Effects on cardiovascular risks and disease, protective effects against cancer, and clinical adverse effects. Evidence Report/Technology Assessment No. 20 (Contract 290-97-0012 to the San Antonio Evidence-Based Practice Center based at the University of Texas Health Science Center at San Antonio and the Veterans Evidence-Based Research, Dissemination, and Implementation Center, a Veterans Affairs Health Services Research and Development Center of Excellence). AHRQ Publication NO. 01-E023. Rockville, MD: Agency for Healthcare Research and Quality; 2000.

    Google Scholar 

  22. Warshafsky S, Kamer RS, Sivak SL: Effect of garlic on total serum cholesterol. A meta-analysis. Ann Intern Med 1993, 119:599–605.

    PubMed  CAS  Google Scholar 

  23. Silagy C, Neil H: Garlic as a lipid lowering agent—a meta-analysis. J R Coll Physicians Lond 1994, 28:39–45.

    PubMed  CAS  Google Scholar 

  24. Simons LA, Balasubramaniam S, von Konigsmark M, et al.: On the effect of garlic on plasma lipids and lipoproteins in mild hypercholesterolaemia. Atherosclerosis 1995, 113:219–225.

    Article  PubMed  CAS  Google Scholar 

  25. Neil HA, Silagy CA, Lancaster T, et al.: Garlic powder in the treatment of moderate hyperlipidaemia: a controlled trial and meta-analysis. J R Coll Physicians Lond 1996, 30:329–334.

    PubMed  CAS  Google Scholar 

  26. Berthold HK, Sudhop T, von Bergmann K: Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial. JAMA 1998, 279:1900–1902.

    Article  PubMed  CAS  Google Scholar 

  27. Isaacsohn JL, Moser M, Stein EA, et al.: Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med 1998, 158:1189–1194.

    Article  PubMed  CAS  Google Scholar 

  28. Superko HR, Krauss RM: Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a). J Am Coll Cardiol 2000, 35:321–326.

    Article  PubMed  CAS  Google Scholar 

  29. Gardner CD, Chatterjee LM, Carlson JJ: The effect of a garlic preparation on plasma lipid levels in moderately hypercholesterolemic adults. Atherosclerosis 2001, 154:213–220.

    Article  PubMed  CAS  Google Scholar 

  30. Kannar D, Wattanapenpaiboon N, Savige GS, Wahlqvist ML: Hypocholesterolemic effect of an enteric-coated garlic supplement. J Am Coll Nutr 2001, 20:225–231.

    PubMed  CAS  Google Scholar 

  31. Adler JA, Holub BJ: Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men. Am J Clin Nutr 1997, 65:445–450.

    PubMed  CAS  Google Scholar 

  32. Steiner M, Khan AH, Holbert D, Lin RI: A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. Am J Clin Nutr 1996, 64:866–870.

    PubMed  CAS  Google Scholar 

  33. Stevinson C, Pittler MH, Ernst E: Garlic for treating hypercholesterolemia. A meta-analysis of randomized clinical trials. Ann Intern Med 2000, 133:420–429.

    PubMed  CAS  Google Scholar 

  34. Ackermann RT, Mulrow CD, Ramirez G, et al.: Garlic shows promise for improving some cardiovascular risk factors. Arch Intern Med 2001, 161:813–824.

    Article  PubMed  CAS  Google Scholar 

  35. Lawson LD, Wang ZJ: Allicin release from garlic supplements: a major problem due to the sensitivities of allinase activity. J Agric Food Chem 2001, 49:2592–2599.

    Article  PubMed  CAS  Google Scholar 

  36. Lawson LD, Wang ZJ, Papadimitriou D: Allicin release under simulated gastrointestinal conditions from garlic powder tablets employed in clinical trials on serum cholesterol. Planta Medica 2001, 67:13–18.

    Article  PubMed  CAS  Google Scholar 

  37. Kressmann S, Bibier A, Wonnemann M, et al.: Influence of pharmaceutical quality on the bioavailability of active components from Ginkgo biloba preparations. J Pharm Pharmacol 2002, 54:1507–1514.

    Article  PubMed  CAS  Google Scholar 

  38. Pittler MH, Ernst E: Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med 2000, 108:276–281.

    Article  PubMed  CAS  Google Scholar 

  39. Dawson DL, Hiatt WR, Creager MA, Hirsch AT: Peripheral artery disease: medical care and prevention of complications. Prevent Cardiol 2002, 5:119–130.

    Google Scholar 

  40. Yan LJ, Droy-Lefaix MT, Packer L: Ginkgo biloba extract (EGb 761) protects human low density lipoproteins against oxidative modification mediated by copper. Biochem Biophys Res Commun 1995, 212:360–366.

    Article  PubMed  CAS  Google Scholar 

  41. Maitra I, Marcocci L, Droy-Lefaix MT, Packer L: Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761. Biochem Pharmacol 1995, 49:1649–1655.

    Article  PubMed  CAS  Google Scholar 

  42. Kudolo GB, Dorsey S, Bolodgett J: Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. Thromb Res 2002, 108:151–160.

    Article  PubMed  CAS  Google Scholar 

  43. Gozin A, Da Cost L, Andrieu V, et al.: Oxygen radicals activate neutrophil adhesion to and tyrosine phosphorylation in endothelial cells: effect of the antioxidant Ginkgo biloba extract (EGb 761). In Advances in Ginkgo biloba Extract Research, Vol 7. Ginkgo biloba Extract (EGb 761): Lessons from Cell Biology. Edited by Packer L, Christen Y. Paris: Elsevier; 1998.

    Google Scholar 

  44. Mehlsen J, Drabaek H, Wiinberg N, Winther K: Effects of a Ginkgo biloba extract on forearm haemodynamics in healthy volunteers. Clin Physiol Funct Imag 2003, 22:375–378.

    Article  Google Scholar 

  45. Roy S, Koburchi H, Sen CK, et al.: Ginkgo biloba extract (EGb 761): antioxidant properties and regulation of gene expression. In Advances in Ginkgo biloba Extract Research, Vol 7. Ginkgo biloba Extract (EGb 761): Lessons from Cell Biology. Edited by Packer L, Christen Y. Paris: Elsevier; 1998.

    Google Scholar 

  46. Auguet M, Delaflotte S, Chabrier PE, Braquet P: Ginkgo biloba extract (EGb 761) and the regulation of vascular tone. In Advances in Ginkgo biloba Extract Research, Vol 3. Cardiovascular Effects of Ginkgo biloba Extract (EGb 761). Edited by Clostre F, DeFeudis FV. Paris: Elsevier; 1994.

    Google Scholar 

  47. Fessenden JM, Wittenborn W, Clarke L: Ginkgo biloba: a case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy. Am Surg 2001, 67:33–35.

    PubMed  CAS  Google Scholar 

  48. Hauser D, Gayowski T, Singh N: Bleeding complications precipitated by unrecognized Ginkgo biloba use after liver transplants. Transpl Int 2002, 15:377–379.

    Article  PubMed  Google Scholar 

  49. Rowin J, Lewis SL: Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996, 46:1775–1776.

    PubMed  CAS  Google Scholar 

  50. Vale S: Subarachnoid haemorrhage associated with Ginkgo biloba. Lancet 1998, 352:36.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stanford Center for Research in Disease Prevention, Stanford University Medical School, 730 Welch Road, Suite B, 94304-1583, Palo Alto, CA, USA

    Christopher D. Gardner PhD, Mark Messina PhD, Larry D. Lawson PhD & John W. Farquhar MD

Authors
  1. Christopher D. Gardner PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark Messina PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Larry D. Lawson PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John W. Farquhar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gardner, C.D., Messina, M., Lawson, L.D. et al. Soy, garlic, and ginkgo biloba: Their potential role in cardiovascular disease prevention and treatment. Curr Atheroscler Rep 5, 468–475 (2003). https://doi.org/10.1007/s11883-003-0037-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-003-0037-7

Keywords

Search

Navigation